Source: Global Network
[Global Network Reporter Lin Zeyu] Japan's new crown vaccination venue has previously discovered that the same batch of American Moderna vaccines contained visible impurities, Japan's Ministry of Health, Labor and Welfare has now suspended the use of about 100 vaccines produced by the factory involved. 1.63 million doses of vaccine. However, Japan's "Yomiuri Shimbun" reported on the 29th that some vaccines had been administered before the Ministry of Health, Labor and Welfare ordered the suspension of use. Two men in their 30s with no underlying diseases died after receiving the vaccine in question. .
"Yomiuri Shimbun": Impurities were found in the vaccine, and the vaccine manufactured by the factory involved was suspended. Two men in their 30s with no underlying diseases have died after receiving the vaccine manufactured by the factory.
According to "Yomiuri Shimbun" According to reports, the vaccine found to have impurities was manufactured by a factory in Spain, and the batch number was "3004667". After the impurities were found, the Ministry of Health, Labor and Welfare ordered the suspension of the use of "3004667", "3004734" and "3004956" produced by the factory. "The batch contains approximately 1.63 million doses of vaccine.
"Yomiuri Shimbun" stated that as of the 25th, 9 people had reported adverse reactions after receiving the "3004667" batch vaccine, and 13 people had adverse reactions after receiving the "3004734" batch vaccine, including two in their 30s. , men without underlying diseases died after receiving this batch of vaccines. There have been no reports of adverse reactions after vaccination with the "3004956" batch of vaccines.
Data map of Moderna vaccine solution bottles (Photo source: foreign media)
According to the "Yomiuri Shimbun" report, one of the 38-year-old men developed fever symptoms after receiving the vaccine in question on the 15th. The fever subsided on the 17th, but he died on the 18th. He was found dead at home on the 22nd. Another 30-year-old man also developed fever symptoms after receiving the vaccine in question on the 22nd. His fever subsided temporarily on the 24th and he went to work as usual, but died on the morning of the 25th.
According to Japanese local media reports on the 30th, the family members of the 30-year-old male deceased said in an interview that the deceased not only had no underlying diseases, but also had no history of allergies, and had no habit of smoking or drinking. The father of the deceased revealed during the interview, "I didn't expect that my son would (die). I was so lonely that I couldn't help myself."
The father of the deceased was interviewed by Japanese local media
According to Japanese Broadcasting Association (NHK) reported on the 28th, in response to the death cases after vaccination with the vaccine produced by the factory involved, the American company Moderna responded, "It will cooperate with The Ministry of Health, Labor and Welfare will cooperate with the Ministry of Health, Labor and Welfare to urgently and openly and transparently investigate the vaccine involved, and the results will be made public as soon as the investigation is clear.
According to previous reports by Japanese media, the Ministry of Health, Labor and Welfare said on the 26th that it had received reports from multiple vaccination venues in Japan. The reports showed that "impurities in some Moderna vaccines will be attracted by magnets and may contain metal components." The Fuji News Network (FNN) report quoted a Ministry of Health, Labor and Welfare official as saying that the impurities may be metal flakes.
Japan Ministry of Health, Labor and Welfare data map (Picture source: Japanese media)
According to NHK reports on the 29th, it was discovered at vaccination sites in Okinawa Prefecture and Gunma Prefecture that Moderna vaccine was once again found to be adulterated with impurities, and The batch numbers are inconsistent with the "3004667", "3004734" and "3004956" batches of vaccines ordered by the Ministry of Health, Labor and Welfare to suspend use.
